Langerhans Cells Do Not Produce Interferon-γ  by Tada, Yayoi et al.
Langerhans Cells Do Not Produce Interferon-c
To the Editor:
Interferon-g (IFN-g) is the predominant cytokine during Th1-
dominated immune reactions, participates importantly during
antigen presentation, and is the prototypical macrophage-activat-
ing cytokine. Consequently, a pivotal role of IFN-g in the clear-
ance of various intracellular pathogens has been demonstrated
(Boehm et al, 1997). IFN-g had historically been regarded as a
product solely of T cells and natural killer cells; however, it was
discovered recently that, with appropriate stimulation, B cells,
macrophages (Mf), and even dendritic cells (DC) could produce
IFN-g (Di Marzio et al, 1994; Yoshimoto et al, 1997; Ohteki et al,
1999). In the case of DC, IL-18 acts in synergy with IL-12 on
IFN-g production (Fukao et al, 2000). In addition, IL-4 unexpect-
edly enhances DC IFN-g production, synergistically with IL-12
or with DC stimulation through CD40 or major histocompat-
ibility complex class II molecules triggering endogenous IL-12
production (Fukao et al, 2000). Therefore, we were interested in
examining whether Langerhans cells, a special subset of DC lo-
calized in the epidermis, could produce IFN-g in response to
these stimulations. Recently, we succeeded in preparing high pur-
ity Langerhans cells (495%) from BALB/c mouse skin (Tada
et al, 2000), and this allowed us to examine direct e¡ects of several
cytokines on Langerhans cell IFN-g production, without inter-
ference of keratinocytes and keratinocyte-derived cytokines.
First, we employed reverse transcription polymerase chain re-
action (RT-PCR) to assess IFN-g gene expression in Langerhans
cells exposed to various combined stimulations including IL-12
(2 ng per ml), IL-18 (20 ng per ml), IL-4 (10 ng per ml), and
IFN-g (100 ng per ml), as shown in Fig 1. These stimulations
were formerly reported to induce IFN-g production in both
spleen- and bone-marrow-derived DC or Mf (Di Marzio et al,
1994; Fukao et al, 2000; Stober et al, 2001). As shown in Fig 1, no
IFN-g mRNAwas detected in any of the RNA extracted from
fresh Langerhans cells and 24 h incubated Langerhans cells with
and without stimulation. As expected, IFN-g mRNA was de-
tected in spleen-derived CD11cþ DC stimulated with IL-12 and
IL-18.
Next, supernatants of 48 h cultured Langerhans cells and DC
were subjected to the measurement of IFN-g protein levels using
enzyme-linked immunosorbent assay (ELISA). The synergistic
e¡ects of IL-4 and IL-18 on IL-12-dependent IFN-g production
of spleen-derived CD11cþ DC previously reported by Fukao et al
(2000) were con¢rmed (Fig 2A). In contrast to spleen-derived
CD11cþ DC, simultaneous addition of IL-12 and IL-18 failed to
induce Langerhans cell IFN-g secretion (Fig 2B). Further admin-
istration of IL-4 to the combination of IL-12 and IL-18 did not
a¡ect this Langerhans cell unresponsiveness (Fig 2B). IL-15, re-
cently characterized as another IFN-g-inducing cytokine from
DC (Mattei et al, 2001), also failed to stimulate Langerhans cells
for IFN-g production (data not shown). We also evaluated the
e¡ect of other stimulations closely related to Langerhans cell
maturation and IL-12 production (Tada et al, 2001), such as
anti-CD40 monoclonal antibody (20 mg per ml), granulocy-
temacrophage colony stimulating factor (1 ng per ml), tumor
necrosis factor a (10 ng per ml), IFN-b (1000 U per ml), anti-IL-10
monoclonal antibody (20 mg per ml), transforming growth factor
b (TGF-b; 1 ng per ml), and the combination of anti-CD40
monoclonal antibody and TGF-b. None of these reagents caused
Langerhans cell IFN-g production, however, even when added
together with IL-12, IL-18, and IL-4 (data not shown). The same
results were obtained with both 48 h and 72 h cultured Langer-
hans cells.
We used only dispase for epidermal sheet separation from the
mouse skin, and did not use trypsin throughout the process of
Langerhans cell isolation.With this isolation technique, receptors
of cytokines are less likely to be degraded on Langerhans cells.
The whole procedure may have a¡ected expression of cell surface
receptors, however, causing Langerhans cells to be unresponsive
to several cytokines in comparison to spleen-derived CD11cþ
DC. To address this issue, we treated DC in the same condition
that was employed for Langerhans cell isolation, but the viability
of treated DC then fell signi¢cantly and an exact comparison was
not possible (Tada et al, 2000). As another approach, we left iso-
lated Langerhans cells untreated in culture medium for 24 h be-
fore the addition of stimuli, in order to allow reappearance of cell
surface receptors putatively degraded by the isolation procedure.
This experiment also failed to stimulate Langerhans cells for
IFN-g production (data not shown). Finally, we have recently
found out that IL-12, an important IFN-g inducer of splenic
DC, strongly enhances the level of IFN-inducible protein 10 (IP-10)
production of isolated Langerhans cells prepared in the same way
(Fujita et al, submitted), indicating that IL-12 indeed has a biolo-
gic activity on Langerhans cells.
Figure1. IFN-c mRNA was not detected in any of the stimulated
Langerhans cells. IFN-g mRNA expressions of stimulated Langerhans
cells and spleen-derived CD11cþ DC of BALB/c mice were analyzed using
RT-PCR, as previously described (Tada et al, 2000). Messenger RNAwas
obtained from Langerhans cells and DC at 0 h and 24 h after stimulation as
indicated. The primers used were: IFN-g (227 bp) sense, GCTCTGAGA-
CAATGAACGCT; IFN-g antisense, AAAGAGATAATCTGGCTCTGC;
glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 659 bp) sense,
GAGGAGCGAGACCCCACTAA; GAPDH antisense, GGCATCGAAG-
GTGGAAGAGT. The denaturing, annealing, and extension were per-
formed for 35 cycles at 951C for 1 min, 581C for 1min, and 721C for 2 min,
respectively.
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It is likely that IFN-g production by DC plays an important
role in innate immunity and subsequent Th1 responses, and
IFN-g also primes and activates Mf and DC themselves to pro-
duce IL-12, which act on DC and Mf to further induce IFN-g
production. In this context, it is rather surprising that Langerhans
cells do not respond to such stimulations that are known to in-
duce IFN-g production of DC and Mf, although the possibility
still remains that Langerhans cells may secrete IFN-g under some
other conditions. It has also been shown, however, that splenic
CD8þ DC produce more IFN-g than do CD8^ DC after sti-
mulation with IL-12 (Ohteki et al, 1999). Another report argues
that splenic CD4^CD8^ DC, but not CD4CD8þ DC or
CD4þCD8^ DC, produce the highest amount of IFN-g (Ho-
chrein et al, 2001). The reason for the discrepancy between these
two results is uncertain, but the results at least indicate that the
ability of DC to produce IFN-g depends on their subsets.
The skin covers the surface of the body, and it is frequently
exposed to various pathogens. Therefore, our ¢nding may be rea-
sonable in preventing excessive IFN-g production and exagger-
ated skin in£ammation leading to skin damage. Otherwise,
other cell types may substitute for Langerhans cells as a source
of IFN-g in the skin. Similarly to Langerhans cells, keratinocytes
have been shown not to produce IFN-g by any means (Akiba
et al, 2001). In mouse skin, however, we have previously reported
that dendritic epidermal T cells produce IFN-g by the synergistic
e¡ect of IL-12 and IL-18 (Sugaya et al, 1999). In addition, these
cells are known to possess a capacity to kill relevant skin-derived
tumor targets (Kaminski et al, 1993). It is very likely that dendritic
epidermal T cells play an important role in protecting the mouse
skin together with Langerhans cells in the innate immunity. In
human skin, however, the cells corresponding to mouse dendritic
epidermal T cells remain to be elucidated.
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Figure 2. E¡ect of cytokines on IFN-c production of DC and Lan-
gerhans cells. Spleen-derived CD11cþ DC (A) and Langerhans cells
1.5106 per ml (B) were cultured with IL-12 (0.1, 1 ng per ml), IL-18 (0.1,
1, 10 ng per ml), and/or IL-4 (1, 10 ng per ml) for 48 h. The supernatants
were collected and IFN-g contents were measured by a mouse IFN- ELISA
kit. Results are mean7SE (n¼ 3).
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